These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24469316)

  • 21.
    Peng B; Tong Z; Tong WY; Pasic PJ; Oddo A; Dai Y; Luo M; Frescene J; Welch NG; Easton CD; Thissen H; Voelcker NH
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56753-56766. PubMed ID: 33226228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for evaluating nanoparticle transport through the blood-brain barrier in vitro.
    Guarnieri D; Muscetti O; Netti PA
    Methods Mol Biol; 2014; 1141():185-99. PubMed ID: 24567140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain microvessel endothelial cells responses to gold nanoparticles: In vitro pro-inflammatory mediators and permeability.
    Trickler WJ; Lantz SM; Murdock RC; Schrand AM; Robinson BL; Newport GD; Schlager JJ; Oldenburg SJ; Paule MG; Slikker W; Hussain SM; Ali SF
    Nanotoxicology; 2011 Dec; 5(4):479-92. PubMed ID: 21175299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood-Brain Barrier.
    Song Y; Du D; Li L; Xu J; Dutta P; Lin Y
    ACS Appl Mater Interfaces; 2017 Jun; 9(24):20410-20416. PubMed ID: 28541655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.
    Jallouli Y; Paillard A; Chang J; Sevin E; Betbeder D
    Int J Pharm; 2007 Nov; 344(1-2):103-9. PubMed ID: 17651930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The blood-brain barrier studied in vitro across species.
    Thomsen MS; Humle N; Hede E; Moos T; Burkhart A; Thomsen LB
    PLoS One; 2021; 16(3):e0236770. PubMed ID: 33711041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties.
    Takata F; Dohgu S; Yamauchi A; Matsumoto J; Machida T; Fujishita K; Shibata K; Shinozaki Y; Sato K; Kataoka Y; Koizumi S
    PLoS One; 2013; 8(1):e55166. PubMed ID: 23383092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of neuronal and angiogenic growth factors in an in vitro blood-brain barrier model system: Relevance in barrier integrity and tight junction formation and complexity.
    Freese C; Hanada S; Fallier-Becker P; Kirkpatrick CJ; Unger RE
    Microvasc Res; 2017 May; 111():1-11. PubMed ID: 27988246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
    Kuo YC; Lee CL
    Colloids Surf B Biointerfaces; 2012 Feb; 90():75-82. PubMed ID: 22024400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate Receptor α-Modified Nanoparticles for Targeting of the Central Nervous System.
    Kuplennik N; Lang K; Steinfeld R; Sosnik A
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39633-39647. PubMed ID: 31532618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copper transport mediated by nanocarrier systems in a blood-brain barrier in vitro model.
    Fehse S; Nowag S; Quadir M; Kim KS; Haag R; Multhaup G
    Biomacromolecules; 2014 May; 15(5):1910-9. PubMed ID: 24725062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
    De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
    J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Region-specific permeability of the blood-brain barrier upon pericyte loss.
    Villaseñor R; Kuennecke B; Ozmen L; Ammann M; Kugler C; Grüninger F; Loetscher H; Freskgård PO; Collin L
    J Cereb Blood Flow Metab; 2017 Dec; 37(12):3683-3694. PubMed ID: 28273726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organization of Endothelial Cells, Pericytes, and Astrocytes into a 3D Microfluidic in Vitro Model of the Blood-Brain Barrier.
    Wang JD; Khafagy el-S; Khanafer K; Takayama S; ElSayed ME
    Mol Pharm; 2016 Mar; 13(3):895-906. PubMed ID: 26751280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier.
    Cox A; Vinciguerra D; Re F; Magro RD; Mura S; Masserini M; Couvreur P; Nicolas J
    Eur J Pharm Biopharm; 2019 Sep; 142():70-82. PubMed ID: 31176723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier dysfunction induced by silica NPs in vitro and in vivo: Involvement of oxidative stress and Rho-kinase/JNK signaling pathways.
    Liu X; Sui B; Sun J
    Biomaterials; 2017 Mar; 121():64-82. PubMed ID: 28081460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles.
    Trickler WJ; Lantz-McPeak SM; Robinson BL; Paule MG; Slikker W; Biris AS; Schlager JJ; Hussain SM; Kanungo J; Gonzalez C; Ali SF
    Drug Metab Rev; 2014 May; 46(2):224-31. PubMed ID: 24378227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
    Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.
    Moura RP; Almeida A; Sarmento B
    Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
    Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
    Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.